Cargando…
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis
Many studies have investigated the association between alterations in the p53 gene and clinical outcome of breast cancer, and most investigators have reported poorer overall and disease-free survival (as indicated by a relative hazard (RH) greater than one) in breast cancer cases with somatic mutati...
Autores principales: | Pharoah, P D P, Day, N E, Caldas, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363143/ https://www.ncbi.nlm.nih.gov/pubmed/10471047 http://dx.doi.org/10.1038/sj.bjc.6690628 |
Ejemplares similares
-
p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001) -
Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination
por: Yu, H, et al.
Publicado: (1999) -
Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001) -
Mutation analysis of P73 and TP53 in Merkel cell carcinoma
por: Gele, M Van, et al.
Publicado: (2000) -
Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
por: Lenner, P, et al.
Publicado: (1999)